Home
Conditions
Recurrent Adult Primary Liver Cancer

Clinical trial condition

Recurrent Adult Primary Liver Cancer

Explore clinical trials studying Recurrent Adult Primary Liver Cancer. Study availability and eligibility vary by location and protocol.

25 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Adult Primary Liver Cancer trial results

Active, not recruiting

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

NCT02119065

Conditions: Adenocarcinoma, Advanced Adult Primary Liver Cancer, Carcinoma, +12 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

NCT02088775

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +19 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

NCT01730937

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +11 more
Locations: Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UCSF Medical Center-Mount Zion San Francisco, California, United States

UCSF Medical Center-Mission Bay San Francisco, California, United States

View all 51 locations

View Trial Details

Completed

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

NCT01624285

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Carcinoma, +12 more
Locations: University of Alabama Birmingham, Alabama, United States

Jonsson Comprehensive Cancer Center Los Angeles, California, United States

University of Colorado Denver, Colorado, United States

Mount Sinai Hospital Hartford, Connecticut, United States

View all 21 locations

View Trial Details

Completed

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

NCT02072356

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

NCT01766219

Conditions: Adenocarcinoma, Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, +21 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

NCT00101036

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +22 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NCT00321594

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

Cancer Therapeutics Research Group Singapore

View Trial Details

Completed

Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer

NCT00055692

Conditions: Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Carcinoma, +11 more
Locations: Montefiore Medical Center - Moses Campus The Bronx, New York, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recurrent Adult Primary Liver Cancer

Recurrent Adult Primary Liver Cancer trial results

Related conditions